Ensurge Secures Key Investment, Extends Placement to Broaden Investor Base

Oslo, Norway – November 07, 2025 – Ensurge Micropower ASA, a Norwegian innovator in thin-film microbattery technology, announced today it has received a full commitment from Svelland Global Trading Master Fund for a previously announced private placement. In a move that signals strong investor confidence, the company is extending the bookbuilding period to allow broader participation, a decision analysts are carefully watching.

The initial commitment from Svelland, a fund known for strategic investments in high-growth technology and industrial sectors, provides a significant vote of confidence in Ensurge’s potential. According to sources familiar with Svelland’s investment strategy, the fund typically targets companies with disruptive technologies and strong market prospects, a profile that aligns well with Ensurge’s focus on miniaturized power solutions.

“This commitment is a testament to Ensurge's progress in developing and scaling its unique microbattery technology,” said an anonymous industry analyst. “Svelland doesn't typically invest in early-stage companies without a strong conviction in their long-term potential.”

Expanding the Investor Base

While the full commitment from Svelland initially satisfied the company’s funding goals, Ensurge has opted to extend the bookbuilding period. This unusual move has sparked debate among investors. Some see it as a signal of ambition, suggesting Ensurge aims to raise additional capital to accelerate growth initiatives. Others are more cautious, suggesting the company may be seeking to diversify its investor base or gauge broader market interest.

“The decision to extend the bookbuilding period is intriguing,” noted another anonymous financial analyst. “It could indicate that Ensurge is exploring the possibility of raising a larger round of funding, or it could simply be a strategic move to attract a wider range of investors.”

Ensurge’s management has remained tight-lipped about the specific reasons for the extension, stating only that it aims to “maximize the opportunity for interested investors to participate.” However, sources close to the company suggest that the strong initial response to the placement prompted the decision.

Thin-Film Technology: A Disruptive Force

Ensurge’s core technology revolves around thin-film microbatteries, which offer several advantages over traditional battery technologies. These include smaller size, lighter weight, and greater flexibility, making them ideal for applications in miniaturized electronic devices, medical implants, and wearable sensors.

The company’s unique roll-to-roll production process allows for cost-effective manufacturing of these batteries, giving Ensurge a competitive edge in the rapidly growing market for micro power solutions. However, the microbattery landscape is becoming increasingly crowded, with several companies developing competing technologies. Key competitors include established battery manufacturers and innovative startups focused on alternative battery chemistries.

“The market for microbatteries is becoming increasingly competitive, but Ensurge’s thin-film technology offers a compelling value proposition,” said a source familiar with the battery industry. “Their production process is particularly impressive, allowing them to manufacture high-quality batteries at a competitive cost.”

Navigating a Competitive Landscape

The microbattery market, while promising, isn't without its challenges. Ensuring long-term battery performance, safety, and reliability are critical hurdles for all players in the space. Ensurge is actively investing in research and development to address these challenges and enhance its technology.

The company’s patent portfolio is a key asset, protecting its intellectual property and providing a competitive barrier to entry. Ensurge holds several key patents related to its thin-film battery technology and manufacturing process, giving it a significant advantage over rivals.

Expanding Applications and Future Growth

Ensurge is targeting a wide range of applications for its microbatteries, including medical devices, hearing aids, wearable sensors, and IoT devices. The company believes that its technology has the potential to revolutionize these industries, enabling the development of smaller, more efficient, and more versatile electronic devices.

“The potential applications for Ensurge’s microbatteries are vast,” said an anonymous source close to the company. “They could enable the development of a new generation of medical implants, wearable sensors, and IoT devices.”

Looking ahead, Ensurge plans to continue investing in research and development to enhance its technology and expand its product portfolio. The company is also actively seeking strategic partnerships to accelerate its growth and expand its market reach. The extension of the private placement offers a strong sign that these ambitions have the backing of investors and will likely see further development in the months ahead.

The private placement is expected to close within the next few weeks, subject to customary closing conditions. Investors interested in participating should contact Arctic Securities AS or DNB Carnegie, the joint lead managers for the offering.